Please register (it's free!) or login to view the remaining preview.

If you are logged in, your referral link [?] is automatically included below.

EMBED CODE (Copy and Paste)

BENEFITS OF DOCUMENT

The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025
Currently approved therapies will continue to have a meaningful impact on the multiple myeloma treatment algorithm and market sales
Major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025

DOCUMENT DESCRIPTION

The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025. Growth will be fueled by the continued uptake and label expansions of current therapies and the expected market entry of four novel, premium-priced therapies. Immunomodulatory agents are, and will remain, the dominant drug class throughout the forecast period and will capture more than 50% of major-market sales in 2025.

Currently approved therapies will continue to have a meaningful impact on the multiple myeloma treatment algorithm and market sales. Lenalidomide is set to retain its position as the sales-leading agent in multiple myeloma, with sales expected to reach more than $11.7 billion across the seven major markets in 2025. Continued penetration of the R/R setting will provide significant revenue, as will its label expansion in the first-line setting, in addition to use in combination with recently approved and emerging agents, such as carfilzomib, ixazomib, elotuzumab, daratumumab, and pembrolizumab.
Introduction
Key Findings
Market Share of Cancer Drug Classes in 2015 and 2025
Market SWOT Analysis
Etiology and Pathophysiology
Key Findings
Expert Insight
Pathophysiology
Anatomy
Subtypes
Staging and Classification
Key Pathways and Drug Targets
Market Outlook
Key Findings
Expert Insight
Market Overview
Market Drivers and Constraints
What Factors Are Driving the Market?
What Factors Are Constraining the Market?

Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Market Overview: Multiple Myeloma PDF document

Market Overview: Multiple Myeloma

Sold by pharmzolgas (this author has 4 documents)

$299.00

ALL FEES INCLUDED

Add to Cart

This business document is categorized under the function(s):

Pharma Industry Strategy, Marketing, & Sales

It applies to Healthcare & Life Sciences

File Type: PDF (pdf)

File Size: 1.9 MB

Number of Pages: 27

Related Topic(s): Healthcare Cancer

Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.

Initial upload date (first version): Mar 8, 2017
Most recent version published: Mar 10, 2017

Ask the Author a Question

Must be logged in Click here to log in

CUSTOMER TESTIMONIALS

"As a young consulting firm, requests for input from clients vary and it's sometimes impossible to provide expert solutions across a broad spectrum of requirements. That was before I discovered Flevy.com.

Through subscription to this invaluable site of a plethora of topics that are key and crucial to consulting, I have been able to exceed expectations and deliver quality advice and solutions to my clients. The quality and expertise of the authors are exemplary and gives me great confidence to use as part of my service offerings.

I highly recommend this company for any consultant wanting to apply international best practice standards in their service offerings. "

– Nishi Singh, Strategist and MD at NSP Consultants

"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor the material for specific purposes helped us to make presentations, knowledge sharing, and toolkit development, which formed part of the overall program collateral. While FlevyPro contains resource material that any consultancy, project or delivery firm must have, it is an essential part of a small firm or independent consultant's toolbox."

– Michael Duff, Managing Director at Change Strategy (UK)

"As an Independent Management Consultant, I find Flevy to add great value as a source of best practices, templates and information on new trends. Flevy has matured and the quality and quantity of the library is excellent. Lastly the price charged is reasonable, creating a win-win value for the customer, Flevy and the various authors. This is truly a service that benefits the consulting industry and associated clients. Thanks for providing this service. "

– Jim Schoen, Principal at FRC Group

"As a consulting firm, we had been creating subject matter training materials for our people and found the excellent materials on Flevy, which saved us 100's of hours of re-creating what already exists on the Flevy materials we purchased."

– Michael Evans, Managing Director at Newport LLC

"As a niche strategic consulting firm, Flevy and FlevyPro frameworks and documents are an on-going reference to help us structure our findings and recommendations to our clients as well as improve their clarity, strength, and visual power. For us, it is an invaluable resource to increase our impact and value."

– David Coloma, Consulting Area Manager at Cynertia Consulting

"I have used FlevyPro for several business applications. It is a great complement to working with expensive consultants. The quality and effectiveness of the tools are of the highest standards."

– Moritz Bernhoerster, Global Sourcing Director at Fortune 500

"My FlevyPro subscription provides me with the most popular frameworks and decks in demand in today’s market. They not only augment my existing consulting and coaching offerings and delivery, but also keep me abreast of the latest trends, inspire new products and service offerings for my practice, and educate me in a fraction of the time and money of other solutions. I strongly recommend FlevyPro to any consultant serious about success."

– Bill Branson, Founder at Strategic Business Architects

"If you are looking for great resources to save time with your business presentations, Flevy is truly a value-added resource. Flevy has done all the work for you and we will continue to utilize Flevy as a source to extract up-to-date information and data for our virtual and onsite presentations!"

– Debbi Saffo, President at The NiKhar Group

"As a consultant requiring up to date and professional material that will be of value and use to my clients, I find Flevy a very reliable resource.

The variety and quality of material available through Flevy offers a very useful and commanding source for information. Using Flevy saves me time, enhances my expertise and ends up being a good decision."

– Dennis Gershowitz, Principal at DG Associates

"I have found Flevy to be an amazing resource and library of useful presentations for lean sigma, change management and so many other topics. This has reduced the time I need to spend on preparing for my performance consultation. The library is easily accessible and updates are regularly provided. A wealth of great information."

– Cynthia Howard RN, PhD, Executive Coach at Ei Leadership

SELECT CUSTOMERS

Since 2012, we have provided best practices to over 5,000 businesses and organizations of all sizes across the world—in over 130 countries. Below is just a very small sample of our customer base.

Did you know?

The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

CUSTOMERS ALSO BOUGHT THESE DOCUMENTS

Healthcare Business Capability Model 1-page PDF document $30.00 Author: R Bradley Consulting Healthcare	Pharma launch plan 2020 57-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Lean Healthcare 180-slide PowerPoint deck $79.00 Author: Operational Excellence Consulting Healthcare	Healthcare Go-to-Market Strategy 65-slide PowerPoint deck $49.00 Author: PPT Lab Healthcare
Pharma Field Force Effectiveness Guide 211-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Pharma Marketing Plan 2.0 277-slide PowerPoint deck $199.00 Author: BigPharma2000 Healthcare	Pharma Brand Plan 39-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Key Account Management (KAM) in Healthcare and Pharma 23-slide PowerPoint deck $20.00 This is a FlevyPro [?] document. Subscribe and save with FlevyPro! Healthcare
Pharma Disease Insight: Colorectal Cancer 28-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Pharma Brand Building 183-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Big Pharma: Brand Plan (German Style) 39-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	ISO 13485:2016 (Medical Devices - QMS) Awareness 72-slide PowerPoint deck $69.00 Author: Operational Excellence Consulting Quality Management & Assurance Healthcare